Rhythm Pharmaceuticals, Inc.

RYTM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$89,137$60,081$127,677$59,248
Short-Term Investments$231,428$215,765$205,611$235,607
Receivables$18,512$14,867$6,224$1,025
Inventory$18,741$8,624$2,917$111
Other Curr. Assets$16,382$8,931$11,807$12,396
Total Curr. Assets$374,200$308,268$354,236$308,387
Property Plant & Equip (Net)$4,109$2,122$3,379$4,335
Goodwill$0$0$0$0
Intangibles$6,174$7,028$7,883$4,658
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$7,790$15,327$16,983$12,143
Total NC Assets$18,073$24,477$28,245$21,136
Other Assets$0$0$0$0
Total Assets$392,273$332,745$382,481$329,523
Liabilities
Payables$12,328$4,885$4,797$5,737
Short-Term Debt$0$770$684$606
Tax Payable$0$0$0$0
Deferred Revenue$1,286$1,286$1,434$7,000
Other Curr. Liab.$101,903$48,262$32,894$30,084
Total Curr. Liab.$115,517$55,203$39,809$43,427
LT Debt$3,938$490$1,260$1,945
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$108,269$107,293$77,150$0
Total NC Liab.$112,207$107,783$78,410$1,945
Other Liabilities$0$0$0$0
Cap. Leases$3,938$1,260$1,944$2,551
Total Liabilities$227,724$162,986$118,219$45,372
Equity
Pref Stock$142,820$0$0$0
Common Stock$61$59$56$50
Retained Earnings-$1,155,338-$894,736-$710,058-$528,939
AOCI-$39$134-$92-$1
Other Equity$1,177,045$1,064,302$974,356$813,041
Total Equity$164,549$169,759$264,262$284,151
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$392,273$332,745$382,481$329,523
Net Debt-$85,199-$58,821-$125,733-$56,697